Progression-Free Survival at 24 Months as A Landmark After Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B-cell Lymphoma

Overview of attention for article published in Transplantation and Cellular Therapy, June 2022

Altmetric Badge

Mentioned by

twitter: 2 X users

Readers on

mendeley: 18 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 3,379 followers.

Progression-Free Survival at 24 Months as A Landmark After Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B-cell Lymphoma #lymphoma #lymsm https://t.co/U6vgMMLKYt

New article: Progression-Free Survival at 24 Months as A Landmark After Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B-cell Lymphoma https://t.co/Z3QP9Vvbqs #DLBCL #lymsm #hematology https://t.co/TAczOKGPdC

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.